[DOI] [PubMed] [Google Scholar] 25.Canapp S.O., Jr., Farese J.P., Schultz G.S., Gowda S., Ishak A.M., Swaim S.F., Vangilder J., Lee-Ambrose L., Martin F.G
Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, Kouchaki E, Bahmani F, Borzabadi S, Oryan S, Mafi A, Asemi Z (2019) Clinical and metabolic response to probiotic administration in people with Parkinsons disease: a randomized, double-blind, placebo-controlled trial
Moore, W
Supporting neurotrophic signaling The peptide fragments in Cerebrolysin actively stimulate the production of the brains own endogenous neurotrophic factors while simultaneously providing direct neurotrophic support
The individual agents differ in their unique pharmacology such as half-life and degree of structural homology to GLP-1 [39]
This interaction can play a role in Parkinsons disease, which is caused by damage to dopaminergic neurons in a specific region of the brain